Mirae Asset Nifty 500 Healthcare ETF vs WhiteOak Capital Pharma and Healthcare Fund
Direct Plan where a fund has one, Growth option · Data as on 30-10-2026
Mirae Asset Nifty 500 Healthcare ETF is an ETF fund and WhiteOak Capital Pharma and Healthcare Fund is a Sectoral fund. Mirae Asset Nifty 500 Healthcare ETF charges 0.35% a year and WhiteOak Capital Pharma and Healthcare Fund 1.07%. Their portfolios overlap 57.4%: they hold 27 of the same securities.
Mirae Asset Nifty 500 Healthcare ETF
ETF
- Expense ratio
- 0.35%
- NAV
- ₹21.44
WhiteOak Capital Pharma and Healthcare Fund
Sectoral
- Expense ratio
- 1.07%
- NAV
- ₹17.44
Which is better, Mirae Asset Nifty 500 Healthcare ETF or WhiteOak Capital Pharma and Healthcare? Key differences
It depends on what you want from the fund. These are the differences in numbers, from the data on this page.
- Mirae Asset Nifty 500 Healthcare ETF costs less: 0.35% a year against 1.07%.
- Mirae Asset Nifty 500 Healthcare ETF fell less in its worst fall since 11-02-2026: −9.6% against −9.8%.
- WhiteOak Capital Pharma and Healthcare is the larger fund: ₹927 Cr against ₹15 Cr.
- Their portfolios overlap 57.4%: 27 of the same holdings.
Past returns do not promise future returns. This page is information, not investment advice.
Key facts
From each fund's scheme summary document and AMFI
| Fact | Mirae Asset Nifty 500 Healthcare ETF | WhiteOak Capital Pharma and Healthcare Fund |
|---|---|---|
| Fund house | Mirae Asset Mutual Fund | WhiteOak Capital Mutual Fund |
| Category | ETF | Sectoral |
| AUM | ₹15 Cr (30-09-2026) | ₹927 Cr (30-09-2026) |
| NAV | ₹21.44 | ₹17.44 (Direct) |
| Expense ratio (Direct) | Not available | 1.07% |
| Expense ratio (Regular) | Not available | 2.75% |
| Riskometer | Very High | Very High |
| Benchmark | Nifty500 Healthcare TRI | BSE Healthcare TRI |
| Launch date | Not available | 06-02-2024 |
| Minimum investment | On exchange in multiple of 1 unit. With AMC: In multiples of 5,000 units | ₹500 |
| Lock in | None | None |
| Fund managers | Ekta Gala, amp, Ritesh Patel | Ramesh Mantri, Piyush Baranwal, Dheeresh Pathak, Ashish Agrawal, Trupti Agrawal |
| Exit load | NIL | Nil |
Mirae Asset Nifty 500 Healthcare ETF vs WhiteOak Capital Pharma and Healthcare: Returns Comparison
Returns as on 30-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.
| Fund | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|---|
| Mirae Asset Nifty 500 Healthcare ETF | +1.43% | −0.66% | +12.95% | -- | -- | -- | -- |
| WhiteOak Capital Pharma and Healthcare Fund (Direct) | +0.92% | +1.33% | +17.99% | +19.53% | -- | -- | -- |
| Sectoral average | −1.70% | −4.49% | +2.30% | −0.58% | -- | -- | -- |
Category average: the average of the 20 Sectoral funds, same plan type.
Mirae Asset Nifty 500 Healthcare ETF vs WhiteOak Capital Pharma and Healthcare: Year-wise Returns
| Year | Mirae Asset Nifty 500 Healthcare ETFMirae Asset Nifty 500 Healthcare ETF | WhiteOak Capital Pharma and HealthcareWhiteOak Capital Pharma and Healthcare |
|---|---|---|
| 2026to date | -- | +22.83% |
| 2025 | -- | +1.84% |
Mirae Asset Nifty 500 Healthcare ETF vs WhiteOak Capital Pharma and Healthcare: Rolling Returns
Every holding period of both funds, against Nifty500 Healthcare TRI, the benchmark of Mirae Asset Nifty 500 Healthcare ETF
Mirae Asset Nifty 500 Healthcare ETF vs WhiteOak Capital Pharma and Healthcare: Risk and Drawdowns
How much each fund swings, and the worst fall over the same days
Risk and return
| Measure | Mirae Asset Nifty 500 Healthcare ETF | WhiteOak Capital Pharma and Healthcare Fund (Direct) |
|---|---|---|
| Return (CAGR) | +23.46% | +22.30% |
| Standard deviation | 14.16% | 14.35% |
| Sharpe ratio | 1.29 | 1.14 |
| Sortino ratio | 1.90 | 1.62 |
| Maximum drawdown | −9.6% (23-10-2026) | −15.4% (28-02-2025) |
| Beta | 1.00 | 0.97 |
| Alpha | −0.22% | +7.59% |
From daily NAVs, 11-02-2026 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
Drawdowns
How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.
Mirae Asset Nifty 500 Healthcare ETF
WhiteOak Capital Pharma and Healthcare Fund (Direct)
Nifty500 Healthcare TRI
| Fund | Worst fall | High before it | Bottom | Back at the high | Time to climb back | Below its high today |
|---|---|---|---|---|---|---|
| Mirae Asset Nifty 500 Healthcare ETF | −9.6% | 23-09-2026 | 23-10-2026 | Not yet | -- | −3.0% |
| WhiteOak Capital Pharma and Healthcare Fund (Direct) | −9.8% | 23-09-2026 | 23-10-2026 | Not yet | -- | −3.0% |
| Nifty500 Healthcare TRI | −9.6% | 23-09-2026 | 23-10-2026 | Not yet | -- | −2.9% |
From daily values since 11-02-2026, the first day every fund has.
Mirae Asset Nifty 500 Healthcare ETF vs WhiteOak Capital Pharma and Healthcare: Portfolio Overlap
From each fund's latest monthly portfolio: Mirae Asset Nifty 500 Healthcare ETF, September 2026; WhiteOak Capital Pharma and Healthcare Fund, September 2026
Holdings in common
- Overlap
- 57.4%
- Held by both
- 27
- Only in Mirae Asset Nifty 500 Healthcare ETF
- 17
- Only in WhiteOak Capital Pharma and Healthcare
- 32
| Security | % of Mirae Asset Nifty 500 Healthcare ETF | % of WhiteOak Capital Pharma and Healthcare |
|---|---|---|
| Divi's Laboratories Ltd. | 8.76% | 8.36% |
| Sun Pharmaceutical Industries Ltd. | 10.13% | 7.11% |
| Torrent Pharmaceuticals Ltd. | 5.24% | 6.26% |
| Laurus Labs Ltd. | 5.72% | 3.91% |
| Apollo Hospitals Enterprise Ltd. | 6.24% | 3.75% |
| Cipla Ltd. | 5.62% | 3.68% |
| Zydus Lifesciences Ltd. | 2.14% | 2.81% |
| Aurobindo Pharma Ltd. | 3.43% | 2.09% |
| IPCA Laboratories Ltd. | 1.98% | 2.88% |
| Max Healthcare Institute Ltd. | 5.13% | 1.84% |
| Sai Life Sciences Ltd. | 1.56% | 3.28% |
| Krishna Institute of Medical Sciences Ltd. | 1.48% | 1.85% |
| Neuland Laboratories Ltd. | 1.36% | 2.60% |
| Fortis Healthcare Ltd. | 2.98% | 1.36% |
| Acutaas Chemicals Ltd. | 1.26% | 1.45% |
| Ajanta Pharma Ltd. | 1.22% | 2.01% |
| Mankind Pharma Ltd. | 2.10% | 1.20% |
| Dr. Lal Path labs Ltd. | 1.15% | 2.35% |
| Piramal Pharma Ltd. | 0.95% | 1.06% |
| Gland Pharma Ltd. | 1.71% | 0.93% |
| Narayana Hrudayalaya Ltd. | 0.92% | 1.61% |
| Global Health Ltd. | 0.90% | 1.82% |
| Onesource Specialty Pharma Ltd. | 0.89% | 1.55% |
| Anthem Biosciences Ltd. | 0.69% | 1.57% |
| Vijaya Diagnostic Centre Ltd. | 0.52% | 1.56% |
| Rainbow Children's Medicare Ltd. | 0.49% | 1.15% |
| Biocon Ltd. | 1.91% | 0.42% |
Overlap: for each holding both funds own, the smaller of its two weights, added up. 57.4% means 57.4% of each fund's money sits in positions the other also holds. Matched by ISIN. Cash and hedged positions are left out.
Largest holdings only in Mirae Asset Nifty 500 Healthcare ETF
| Security | % of fund |
|---|---|
| Dr. Reddy's Laboratories Ltd. | 5.58% |
| Lupin Ltd. | 3.66% |
| Glenmark Pharmaceuticals Ltd. | 2.61% |
| Alkem Laboratories Ltd. | 2.31% |
| Aster DM Quality Care Ltd. | 1.38% |
Largest holdings only in WhiteOak Capital Pharma and Healthcare Fund
| Security | % of fund |
|---|---|
| Corona Remedies Limited | 2.34% |
| Thyrocare Technologies Limited | 2.27% |
| Shaily Engineering Plastics Limited | 1.84% |
| Navin Fluorine International Limited | 1.41% |
| Aarti Pharmalabs Limited | 1.20% |
Asset and sector split
Share of each fund, from its latest monthly portfolio
Asset allocation
| Asset | Mirae Asset Nifty 500 Healthcare ETF | WhiteOak Capital Pharma and Healthcare |
|---|---|---|
| Equity | 100.0% | 90.7% |
| Debt | 0.0% | 3.1% |
| Cash and others | 0.0% | 6.1% |
Market cap of stocks
| Market cap | Mirae Asset Nifty 500 Healthcare ETF | WhiteOak Capital Pharma and Healthcare |
|---|---|---|
| Large Cap | 36.0% | 29.2% |
| Mid Cap | 45.6% | 21.7% |
| Small Cap | 18.3% | 37.5% |
| Not on AMFI's list | 0.0% | 2.4% |
Share of the whole fund. Groups follow AMFI's latest list: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.
Largest sectors
| Sector | Mirae Asset Nifty 500 Healthcare ETF | WhiteOak Capital Pharma and Healthcare |
|---|---|---|
| Pharmaceuticals & Biotechnology | 77.8% | 61.2% |
| Healthcare Services | 21.7% | 23.0% |
| Chemicals & Petrochemicals | 0.0% | 3.3% |
| Consumer Durables | 0.0% | 1.8% |
| Healthcare Equipment & Supplies | 0.5% | 1.4% |
The six largest sectors of each fund's stocks, % of the fund.
Mirae Asset Nifty 500 Healthcare ETF vs WhiteOak Capital Pharma and Healthcare: Expense Ratio
What each plan charges a year, from AMFI's expense ratio file
| Charge | Mirae Asset Nifty 500 Healthcare ETF | WhiteOak Capital Pharma and Healthcare Fund |
|---|---|---|
| Total expense ratio (Direct) | Not available | 1.07% |
| Base expense ratio (Direct) | 0.00% | 0.54% |
| Total expense ratio (Regular) | Not available | 2.75% |
| Base expense ratio (Regular) | 0.16% | 1.96% |
The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, transaction costs, and levies with GST.
More comparisons
Each fund against the others of its category
Compare WhiteOak Capital Pharma and Healthcare with
- WhiteOak Capital Pharma and Healthcare vs DSP Healthcare
- WhiteOak Capital Pharma and Healthcare vs Nippon India Pharma
- WhiteOak Capital Pharma and Healthcare vs Bandhan Transportation and Logistics
- WhiteOak Capital Pharma and Healthcare vs Nippon India Power & Infra
- WhiteOak Capital Pharma and Healthcare vs Invesco India Financial Services
Mirae Asset Nifty 500 Healthcare ETF vs WhiteOak Capital Pharma and Healthcare Fund: Frequently Asked Questions
What is the difference between Mirae Asset Nifty 500 Healthcare ETF and WhiteOak Capital Pharma and Healthcare Fund?
Mirae Asset Nifty 500 Healthcare ETF is an ETF fund, WhiteOak Capital Pharma and Healthcare Fund is a Sectoral fund, run by Mirae Asset Mutual Fund and WhiteOak Capital Mutual Fund. Their portfolios overlap 57.4%. Mirae Asset Nifty 500 Healthcare ETF charges 0.35% a year and WhiteOak Capital Pharma and Healthcare Fund 1.07%.
Which has the lower expense ratio, Mirae Asset Nifty 500 Healthcare ETF or WhiteOak Capital Pharma and Healthcare Fund?
Mirae Asset Nifty 500 Healthcare ETF charges less: 0.35% a year against 1.07%. These are the total expense ratios reported to AMFI.
How much do Mirae Asset Nifty 500 Healthcare ETF and WhiteOak Capital Pharma and Healthcare Fund overlap?
57.4%. They hold 27 of the same securities, the largest shared ones being DIVISLAB, SUNPHARMA, TORNTPHARM. From each fund's latest monthly portfolio.
Which is riskier, Mirae Asset Nifty 500 Healthcare ETF or WhiteOak Capital Pharma and Healthcare Fund?
On SEBI's riskometer, Mirae Asset Nifty 500 Healthcare ETF is rated Very High and WhiteOak Capital Pharma and Healthcare Fund Very High. Over their common history, the standard deviation of daily returns was 14.16% and 14.35% a year.
Can I invest in both Mirae Asset Nifty 500 Healthcare ETF and WhiteOak Capital Pharma and Healthcare Fund?
Yes. 57.4% of each fund's money sits in the same holdings, so a large part of the two investments would move together.
Who manages Mirae Asset Nifty 500 Healthcare ETF and WhiteOak Capital Pharma and Healthcare Fund?
Mirae Asset Nifty 500 Healthcare ETF: Ekta Gala, amp, Ritesh Patel. WhiteOak Capital Pharma and Healthcare Fund: Ramesh Mantri, Piyush Baranwal, Dheeresh Pathak, Ashish Agrawal, Trupti Agrawal.
Sources: NAV and expense ratio from AMFI. Holdings from each fund house's monthly portfolio statement. Fund facts from each scheme summary document.
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.